| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:PD-140548
CAS:140677-01-6
Package:25mg/RMB 12800;50mg/RMB 16800;100mg/RMB 21500
|
Benzenebutanoic acid, β-[[(2S)-3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.13,7]dec-2-yloxy)carbonyl]amino]propyl]amino]-, (βR)- manufacturers
- PD-140548
-
- $1820.00 / 25mg
-
2026-01-04
- CAS:140677-01-6
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Benzenebutanoic acid, β-[[(2S)-3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.13,7]dec-2-yloxy)carbonyl]amino]propyl]amino]-, (βR)- Basic information |
| | Benzenebutanoic acid, β-[[(2S)-3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.13,7]dec-2-yloxy)carbonyl]amino]propyl]amino]-, (βR)- Chemical Properties |
| Boiling point | 837.3±65.0 °C(Predicted) | | density | 1.30±0.1 g/cm3(Predicted) | | pka | 4.30±0.10(Predicted) |
| | Benzenebutanoic acid, β-[[(2S)-3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.13,7]dec-2-yloxy)carbonyl]amino]propyl]amino]-, (βR)- Usage And Synthesis |
| Description | PD-140548 is a potent and selective CCKA receptor antagonist. | | Uses | PD-140548 is a selective cholecystokinin (CCKA) receptor antagonist. PD-140548 can be used in schizophrenia research[1]. | | References | [1] Gracey DJ, et al. Differential effects of the CCKA receptor ligands PD-140,548 and A-71623 on latent inhibition in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Apr;26(3):497-504. DOI:10.1016/s0278-5846(01)00296-2 |
| | Benzenebutanoic acid, β-[[(2S)-3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.13,7]dec-2-yloxy)carbonyl]amino]propyl]amino]-, (βR)- Preparation Products And Raw materials |
|